Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Glucagon for Exercise-Induced Hypoglycemia in T1D
NCT05076292Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Nov 2021
- Primary completion
- Aug 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, single-blind trial of glucagon in hypoglycemia (3 arms), sponsored by Steno Diabetes Center Copenhagen. Primary endpoint: Incidence rate of hypoglycemia (PG < 3.9 mmol/l). Started Nov 2021; status: completed.
02
Drugs
glucagon
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT05076292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05076292.